| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.686 | 0.025 | 0.686 | Caspase 9 stimulant | 0.634 0.032 CID_3565 | ||
| 0.652 | 0.01 | 0.68 | 5 Hydroxytryptamine release stimulant | 0.68 0.008 CID_3565 | CID_3565 | |
| 0.629 | 0.005 | 0.65 | Psychostimulant | 0.65 0.005 CID_3565 | CID_3565 | |
| 0.532 | 0.004 | 0.532 | Alpha 2b adrenoreceptor antagonist | 0.427 0.005 CID_3565 | ||
| 0.537 | 0.016 | 0.572 | Calcium channel L-type activator | 0.572 0.009 CID_3565 | CID_3565 | |
| 0.524 | 0.02 | 0.65 | GABA C receptor rho-3 antagonist | 0.65 0.004 CID_3565 | CID_3565 | |
| 0.471 | 0.016 | 0.524 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.524 0.01 CID_3565 | CID_3565 | |
| 0.468 | 0.017 | 0.525 | Dyrk kinase inhibitor | 0.525 0.011 CID_3565 | CID_3565 | |
| 0.45 | 0.005 | 0.68 | Tyrosine 3 hydroxylase inhibitor | 0.68 0.003 CID_3565 | CID_3565 | |
| 0.438 | 0.003 | 0.438 | 5 Hydroxytryptamine 5A antagonist | 0.29 0.004 CID_3565 | ||
| 0.433 | 0.003 | 0.433 | 5 Hydroxytryptamine 5 antagonist | 0.264 0.004 CID_3565 | ||
| 0.423 | 0.005 | 0.423 | 5 Hydroxytryptamine 2C antagonist | 0.247 0.013 CID_3565 | ||
| 0.408 | 0.004 | 0.408 | Alpha 2c adrenoreceptor antagonist | 0.32 0.005 CID_3565 | ||
| 0.454 | 0.053 | 0.56 | 15-Lipoxygenase inhibitor | 0.56 0.03 CID_3565 | CID_3565 | |
| 0.407 | 0.022 | 0.407 | Calcium channel activator | 0.356 0.046 CID_3565 | ||
| 0.381 | 0.005 | 0.381 | Alpha 2a adrenoreceptor antagonist | 0.318 0.006 CID_3565 | ||
| 0.377 | 0.009 | 0.4 | MAO A inhibitor | 0.4 0.009 CID_3565 | CID_3565 | |
| 0.361 | 0.004 | 0.403 | GABA C receptor rho-2 antagonist | 0.403 0.003 CID_3565 | CID_3565 | |
| 0.374 | 0.021 | 0.374 | Cyclic AMP phosphodiesterase inhibitor | 0.374 0.021 CID_3565 | ||
| 0.341 | 0.011 | 0.341 | Phosphodiesterase inhibitor | 0.22 0.029 CID_3565 | ||
| 0.324 | 0.007 | 0.324 | Alpha 2 adrenoreceptor antagonist | 0.244 0.012 CID_3565 | ||
| 0.345 | 0.039 | 0.345 | Tumour necrosis factor alpha release inhibitor | 0.289 0.058 CID_3565 | ||
| 0.341 | 0.036 | 0.363 | Vasodilator | 0.363 0.03 CID_3565 | CID_3565 | |
| 0.396 | 0.104 | 0.396 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.392 0.108 CID_3565 | ||
| 0.31 | 0.019 | 0.31 | MAO inhibitor | 0.31 0.019 CID_3565 | ||
| 0.29 | 0.002 | 0.29 | Imidazoline I1 receptor antagonist | 0.112 0.002 CID_3565 | ||
| 0.283 | 0.018 | 0.283 | 5 Hydroxytryptamine 2 antagonist | 0.171 0.038 CID_3565 | ||
| 0.315 | 0.065 | 0.353 | Spasmolytic | 0.353 0.052 CID_3565 | CID_3565 | |
| 0.258 | 0.014 | 0.258 | 5 Hydroxytryptamine 2A antagonist | 0.142 0.03 CID_3565 | ||
| 0.304 | 0.061 | 0.312 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.312 0.056 CID_3565 | CID_3565 | |
| 0.326 | 0.084 | 0.326 | Vasodilator, peripheral | 0.315 0.089 CID_3565 | ||
| 0.369 | 0.129 | 0.396 | Apoptosis agonist | 0.396 0.115 CID_3565 | CID_3565 | |
| 0.244 | 0.005 | 0.244 | Phosphodiesterase V inhibitor | 0.221 0.005 CID_3565 | ||
| 0.242 | 0.004 | 0.242 | Phosphodiesterase 11A inhibitor | 0.218 0.004 CID_3565 | ||
| 0.242 | 0.004 | 0.242 | Phosphodiesterase XI inhibitor | 0.218 0.004 CID_3565 | ||
| 0.242 | 0.005 | 0.242 | Phosphodiesterase 5A inhibitor | 0.218 0.005 CID_3565 | ||
| 0.216 | 0.01 | 0.22 | MAP3K9 inhibitor | 0.22 0.009 CID_3565 | CID_3565 | |
| 0.212 | 0.006 | 0.274 | GABA C receptor rho-1 antagonist | 0.274 0.004 CID_3565 | CID_3565 | |
| 0.211 | 0.011 | 0.211 | 5 Hydroxytryptamine 7 antagonist | 0.149 0.018 CID_3565 | ||
| 0.209 | 0.011 | 0.225 | Antineoplastic alkaloid | 0.225 0.008 CID_3565 | CID_3565 | |
| 0.255 | 0.058 | 0.255 | Antimitotic | 0.155 0.116 CID_3565 | ||
| 0.339 | 0.143 | 0.339 | MAP kinase 1 inhibitor | 0.246 0.238 CID_3565 | ||
| 0.218 | 0.032 | 0.218 | Tubulin antagonist | 0.128 0.073 CID_3565 | ||
| 0.211 | 0.026 | 0.211 | Alpha adrenoreceptor antagonist | 0.114 0.049 CID_3565 | ||
| 0.224 | 0.043 | 0.246 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.246 0.038 CID_3565 | CID_3565 | |
| 0.249 | 0.075 | 0.249 | 5 Hydroxytryptamine 1E antagonist | 0.232 0.095 CID_3565 | ||
| 0.188 | 0.015 | 0.313 | GABA C receptor antagonist | 0.313 0.004 CID_3565 | CID_3565 | |
| 0.202 | 0.033 | 0.235 | Death-associated protein kinase 2 inhibitor | 0.235 0.017 CID_3565 | CID_3565 | |
| 0.195 | 0.035 | 0.195 | 5 Hydroxytryptamine antagonist | 0.099 0.08 CID_3565 | ||
| 0.297 | 0.138 | 0.297 | MAP kinase kinase 6 inhibitor | 0.291 0.144 CID_3565 | ||
| 0.27 | 0.114 | 0.336 | Transcription factor NF kappa B inhibitor | 0.336 0.081 CID_3565 | CID_3565 | |
| 0.278 | 0.136 | 0.395 | Histamine release inhibitor | 0.395 0.078 CID_3565 | CID_3565 | |
| 0.204 | 0.079 | 0.204 | Platelet aggregation inhibitor | |||
| 0.142 | 0.017 | 0.155 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.155 0.013 CID_3565 | CID_3565 | |
| 0.18 | 0.056 | 0.18 | Cholinergic | 0.134 0.092 CID_3565 | ||
| 0.173 | 0.049 | 0.173 | Toll-Like receptor 9 antagonist | 0.112 0.094 CID_3565 | ||
| 0.16 | 0.038 | 0.178 | DNA intercalator | 0.178 0.033 CID_3565 | CID_3565 | |
| 0.167 | 0.046 | 0.167 | Acetylcholinesterase inhibitor | 0.128 0.071 CID_3565 | ||
| 0.195 | 0.074 | 0.213 | Platelet adhesion inhibitor | 0.213 0.064 CID_3565 | CID_3565 | |
| 0.15 | 0.031 | 0.171 | TRPA1 agonist | 0.171 0.019 CID_3565 | CID_3565 | |
| 0.157 | 0.037 | 0.194 | Cyclin-dependent kinase 5 inhibitor | 0.194 0.024 CID_3565 | CID_3565 | |
| 0.128 | 0.009 | 0.128 | 5 Hydroxytryptamine 6 antagonist | 0.082 0.022 CID_3565 | ||
| 0.209 | 0.1 | 0.383 | Aldehyde oxidase inhibitor | 0.383 0.049 CID_3565 | CID_3565 | |
| 0.288 | 0.179 | 0.319 | 5 Hydroxytryptamine release inhibitor | 0.319 0.144 CID_3565 | CID_3565 | |
| 0.212 | 0.105 | 0.234 | Superoxide dismutase inhibitor | 0.234 0.086 CID_3565 | CID_3565 | |
| 0.119 | 0.012 | 0.119 | Phosphodiesterase VI inhibitor | 0.096 0.023 CID_3565 | ||
| 0.124 | 0.02 | 0.157 | Cyclin B3 inhibitor | 0.157 0.012 CID_3565 | CID_3565 | |
| 0.123 | 0.024 | 0.125 | MAP-kinase-activated kinase inhibitor | 0.125 0.023 CID_3565 | CID_3565 | |
| 0.118 | 0.021 | 0.118 | MAP-kinase-activated kinase 2 inhibitor | 0.117 0.021 CID_3565 | ||
| 0.185 | 0.092 | 0.185 | 5 Hydroxytryptamine 3E antagonist | 0.177 0.115 CID_3565 | ||
| 0.157 | 0.064 | 0.157 | CDC-like kinase 1 inhibitor | 0.136 0.08 CID_3565 | ||
| 0.108 | 0.016 | 0.108 | Toll-Like receptor 7 antagonist | 0.082 0.036 CID_3565 | ||
| 0.126 | 0.035 | 0.126 | Breast cancer-resistant protein inhibitor | 0.087 0.069 CID_3565 | ||
| 0.136 | 0.047 | 0.136 | 5 Hydroxytryptamine 2B antagonist | 0.096 0.089 CID_3565 | ||
| 0.171 | 0.083 | 0.171 | MAP kinase kinase 5 inhibitor | |||
| 0.1 | 0.014 | 0.1 | 5 Hydroxytryptamine 2A agonist | 0.085 0.023 CID_3565 | ||
| 0.177 | 0.091 | 0.177 | Focal adhesion kinase 2 inhibitor | |||
| 0.199 | 0.116 | 0.204 | DNA damaging | 0.204 0.112 CID_3565 | CID_3565 | |
| 0.213 | 0.131 | 0.219 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.219 0.118 CID_3565 | CID_3565 | |
| 0.127 | 0.049 | 0.139 | Photosensitizer | 0.139 0.039 CID_3565 | CID_3565 | |
| 0.138 | 0.062 | 0.195 | Interleukin 4 antagonist | 0.195 0.024 CID_3565 | CID_3565 | |
| 0.111 | 0.035 | 0.121 | Phosphodiesterase 6D inhibitor | 0.121 0.024 CID_3565 | CID_3565 | |
| 0.138 | 0.064 | 0.138 | Toll-Like receptor antagonist | 0.128 0.074 CID_3565 | ||
| 0.149 | 0.075 | 0.168 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.168 0.06 CID_3565 | CID_3565 | |
| 0.183 | 0.11 | 0.183 | ErbB-1 antagonist | 0.172 0.129 CID_3565 | ||
| 0.103 | 0.03 | 0.103 | Phosphodiesterase 3A inhibitor | 0.083 0.052 CID_3565 | ||
| 0.084 | 0.011 | 0.084 | 5 Hydroxytryptamine 7 agonist | 0.063 0.027 CID_3565 | ||
| 0.087 | 0.015 | 0.087 | Phosphodiesterase II inhibitor | 0.069 0.024 CID_3565 | ||
| 0.098 | 0.028 | 0.131 | Dopamine agonist | 0.131 0.018 CID_3565 | CID_3565 | |
| 0.102 | 0.033 | 0.102 | Granulocyte macrophage colony stimulating factor agonist | 0.082 0.07 CID_3565 | ||
| 0.108 | 0.039 | 0.108 | Phosphodiesterase IV inhibitor | |||
| 0.114 | 0.048 | 0.114 | Antiadrenergic | 0.094 0.06 CID_3565 | ||
| 0.125 | 0.059 | 0.125 | Interleukin 1b antagonist | |||
| 0.114 | 0.049 | 0.19 | Carbonic anhydrase III inhibitor | 0.19 0.018 CID_3565 | CID_3565 | |
| 0.11 | 0.048 | 0.11 | Adrenaline antagonist | 0.09 0.06 CID_3565 | ||
| 0.113 | 0.051 | 0.113 | Butyrylcholinesterase inhibitor | |||
| 0.074 | 0.016 | 0.074 | Phosphodiesterase 2A inhibitor | 0.058 0.026 CID_3565 | ||
| 0.168 | 0.112 | 0.245 | Neurotrophic factor enhancer | 0.245 0.041 CID_3565 | CID_3565 | |
| 0.1 | 0.045 | 0.1 | Phosphodiesterase I inhibitor | 0.084 0.069 CID_3565 | ||
| 0.132 | 0.077 | 0.132 | Death-associated protein kinase 1 inhibitor | 0.121 0.108 CID_3565 | ||
| 0.102 | 0.048 | 0.102 | Toll-Like receptor 3 antagonist | |||
| 0.1 | 0.047 | 0.16 | Androgen antagonist | 0.16 0.02 CID_3565 | CID_3565 | |
| 0.081 | 0.031 | 0.081 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.163 | 0.114 | 0.163 | Anticonvulsant | 0.16 0.117 CID_3565 | ||
| 0.091 | 0.042 | 0.117 | Glycine receptor antagonist | 0.117 0.02 CID_3565 | CID_3565 | |
| 0.065 | 0.016 | 0.065 | Alpha 1L adrenoreceptor antagonist | |||
| 0.075 | 0.028 | 0.075 | Bombesin 1 receptor agonist | 0.071 0.031 CID_3565 | ||
| 0.066 | 0.02 | 0.066 | Nicotinic alpha3beta2 receptor antagonist | 0.065 0.022 CID_3565 | ||
| 0.072 | 0.026 | 0.072 | Cyclin D1 inhibitor | |||
| 0.067 | 0.022 | 0.067 | Ryanodine receptor antagonist | |||
| 0.214 | 0.17 | 0.214 | Vasodilator, coronary | |||
| 0.107 | 0.064 | 0.156 | Topoisomerase I inhibitor | 0.156 0.039 CID_3565 | CID_3565 | |
| 0.147 | 0.104 | 0.147 | Tumour necrosis factor antagonist | |||
| 0.129 | 0.086 | 0.129 | Activin receptor-like kinase 2 inhibitor | |||
| 0.123 | 0.081 | 0.125 | Vanilloid 1 agonist | 0.125 0.076 CID_3565 | CID_3565 | |
| 0.082 | 0.04 | 0.117 | MAP kinase kinase 7 inhibitor | 0.117 0.005 CID_3565 | CID_3565 | |
| 0.111 | 0.07 | 0.111 | Platelet activating factor antagonist | |||
| 0.092 | 0.051 | 0.092 | Bromodomain-containing protein 2 inhibitor | |||
| 0.084 | 0.043 | 0.084 | Alpha 1b adrenoreceptor antagonist | |||
| 0.053 | 0.013 | 0.053 | Acid-sensing ion channel blocker | 0.053 0.014 CID_3565 | ||
| 0.063 | 0.024 | 0.063 | 5 Hydroxytryptamine 2 agonist | |||
| 0.056 | 0.019 | 0.064 | Poly(ADP-ribose) polymerase inhibitor | 0.064 0.015 CID_3565 | CID_3565 | |
| 0.151 | 0.114 | 0.194 | Pyruvate kinase inhibitor | 0.194 0.084 CID_3565 | CID_3565 | |
| 0.052 | 0.016 | 0.056 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.056 0.014 CID_3565 | CID_3565 | |
| 0.095 | 0.059 | 0.095 | Alpha 2d adrenoreceptor antagonist | 0.09 0.07 CID_3565 | ||
| 0.187 | 0.153 | 0.197 | Transcription factor STAT3 inhibitor | 0.197 0.138 CID_3565 | CID_3565 | |
| 0.094 | 0.061 | 0.139 | HIV-1 integrase (Overall Integration) inhibitor | 0.139 0.029 CID_3565 | CID_3565 | |
| 0.059 | 0.027 | 0.059 | 5 Hydroxytryptamine 1B agonist | 0.056 0.032 CID_3565 | ||
| 0.05 | 0.02 | 0.052 | Phosphodiesterase 6C inhibitor | 0.052 0.018 CID_3565 | CID_3565 | |
| 0.07 | 0.041 | 0.07 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.08 | 0.051 | 0.121 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.121 0.029 CID_3565 | CID_3565 | |
| 0.093 | 0.065 | 0.093 | Phosphodiesterase 7B inhibitor | |||
| 0.065 | 0.037 | 0.065 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.081 | 0.054 | 0.081 | Acetylcholine nicotinic antagonist | 0.076 0.059 CID_3565 | ||
| 0.115 | 0.089 | 0.127 | NADPH oxidase inhibitor | 0.127 0.075 CID_3565 | CID_3565 | |
| 0.068 | 0.042 | 0.102 | Dopamine D1 antagonist | 0.102 0.024 CID_3565 | CID_3565 | |
| 0.05 | 0.026 | 0.05 | Benzodiazepine antagonist | |||
| 0.132 | 0.108 | 0.164 | MAP kinase kinase 4 inhibitor | 0.164 0.04 CID_3565 | CID_3565 | |
| 0.047 | 0.023 | 0.059 | GABA B receptor antagonist | 0.059 0.013 CID_3565 | CID_3565 | |
| 0.069 | 0.047 | 0.074 | Alpha adrenoreceptor agonist | 0.074 0.042 CID_3565 | CID_3565 | |
| 0.15 | 0.128 | 0.172 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.172 0.103 CID_3565 | CID_3565 | |
| 0.058 | 0.035 | 0.07 | Cyclin B2 inhibitor | 0.07 0.022 CID_3565 | CID_3565 | |
| 0.076 | 0.054 | 0.076 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.062 | 0.041 | 0.062 | Dopamine D4 antagonist | |||
| 0.191 | 0.17 | 0.207 | 5 Hydroxytryptamine uptake stimulant | 0.207 0.138 CID_3565 | CID_3565 | |
| 0.077 | 0.056 | 0.077 | MAP kinase 7 inhibitor | |||
| 0.042 | 0.022 | 0.042 | 5 Hydroxytryptamine 2B agonist | |||
| 0.061 | 0.044 | 0.061 | Dopamine D3 antagonist | |||
| 0.065 | 0.048 | 0.065 | Phosphodiesterase III inhibitor | |||
| 0.035 | 0.02 | 0.035 | Melatonin receptor 1A agonist | |||
| 0.054 | 0.038 | 0.055 | Myc inhibitor | 0.055 0.037 CID_3565 | CID_3565 | |
| 0.057 | 0.042 | 0.071 | Plasminogen activator inhibitor | 0.071 0.031 CID_3565 | CID_3565 | |
| 0.086 | 0.072 | 0.086 | Glutamate release inhibitor | |||
| 0.059 | 0.045 | 0.059 | Phosphodiesterase 1A inhibitor | |||
| 0.142 | 0.128 | 0.142 | I kappa B kinase epsilon inhibitor | |||
| 0.058 | 0.046 | 0.072 | Cyclin B1 inhibitor | 0.072 0.03 CID_3565 | CID_3565 | |
| 0.141 | 0.129 | 0.166 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.166 0.105 CID_3565 | CID_3565 | |
| 0.11 | 0.099 | 0.11 | Calcium channel blocker | |||
| 0.174 | 0.163 | 0.233 | DNA synthesis inhibitor | 0.233 0.08 CID_3565 | CID_3565 | |
| 0.051 | 0.04 | 0.051 | Alpha tubulin antagonist | |||
| 0.059 | 0.048 | 0.059 | Phosphodiesterase VII inhibitor | |||
| 0.024 | 0.014 | 0.024 | Phosphodiesterase 6A inhibitor | 0.022 0.02 CID_3565 | ||
| 0.065 | 0.056 | 0.071 | I kappa B kinase 1 inhibitor | 0.071 0.047 CID_3565 | CID_3565 | |
| 0.095 | 0.086 | 0.123 | Protein kinase C gamma inhibitor | 0.123 0.05 CID_3565 | CID_3565 | |
| 0.054 | 0.045 | 0.054 | Alpha 1d adrenoreceptor antagonist | |||
| 0.03 | 0.021 | 0.031 | Phosphodiesterase 6B inhibitor | 0.031 0.02 CID_3565 | CID_3565 | |
| 0.039 | 0.031 | 0.045 | Phenylethanolamine N methyltransferase inhibitor | 0.045 0.02 CID_3565 | CID_3565 | |
| 0.065 | 0.058 | 0.065 | Dopamine antagonist | |||
| 0.09 | 0.083 | 0.092 | Cyclin-dependent kinase 2 inhibitor | 0.092 0.079 CID_3565 | CID_3565 | |
| 0.137 | 0.131 | 0.142 | Cyclin-dependent kinase 3 inhibitor | 0.142 0.116 CID_3565 | CID_3565 | |
| 0.013 | 0.007 | 0.013 | Melatonin 2 antagonist | |||
| 0.076 | 0.071 | 0.076 | GABA A receptor agonist | |||
| 0.05 | 0.045 | 0.062 | Cyclin B inhibitor | 0.062 0.029 CID_3565 | CID_3565 | |
| 0.067 | 0.063 | 0.097 | Na+ K+ transporting ATPase inhibitor | 0.097 0.034 CID_3565 | CID_3565 | |
| 0.078 | 0.073 | 0.109 | CC chemokine 5 receptor agonist | 0.109 0.014 CID_3565 | CID_3565 | |
| 0.059 | 0.056 | 0.059 | Neuronal nicotinic receptor antagonist | |||
| 0.064 | 0.061 | 0.064 | Benzodiazepine agonist | |||
| 0.165 | 0.165 | 0.182 | Nitric-oxide synthase stimulant | 0.182 0.124 CID_3565 | CID_3565 | |
| 0.047 | 0.046 | 0.047 | GABA A receptor antagonist | 0.047 0.045 CID_3565 | ||
| 0.021 | 0.022 | 0.022 | Phosphodiesterase 6G inhibitor | 0.022 0.019 CID_3565 | CID_3565 | |
| 0.021 | 0.022 | 0.022 | Phosphodiesterase 6H inhibitor | 0.022 0.019 CID_3565 | CID_3565 | |
| 0.047 | 0.049 | 0.05 | GABA receptor antagonist | 0.05 0.044 CID_3565 | CID_3565 | |
| 0.126 | 0.129 | 0.142 | CF transmembrane conductance regulator agonist | 0.142 0.09 CID_3565 | CID_3565 | |
| 0.052 | 0.055 | 0.064 | Alpha 2 adrenoreceptor agonist | 0.064 0.037 CID_3565 | CID_3565 | |
| 0.178 | 0.181 | 0.189 | Hypoxia-inducible factor 1 alpha inhibitor | 0.189 0.165 CID_3565 | CID_3565 | |
| 0.057 | 0.061 | 0.071 | Beta adrenoreceptor antagonist | 0.071 0.037 CID_3565 | CID_3565 | |
| 0.019 | 0.024 | 0.03 | Dopamine D1 agonist | 0.03 0.009 CID_3565 | CID_3565 | |
| 0.045 | 0.052 | 0.077 | Protein kinase C eta inhibitor | 0.077 0.025 CID_3565 | CID_3565 | |
| 0.08 | 0.087 | 0.107 | Protein kinase C zeta inhibitor | 0.107 0.042 CID_3565 | CID_3565 | |
| 0.057 | 0.065 | 0.069 | Beta 3 adrenoreceptor antagonist | 0.069 0.036 CID_3565 | CID_3565 | |
| 0.03 | 0.041 | 0.039 | Alpha 1d adrenoreceptor agonist | 0.039 0.026 CID_3565 | CID_3565 | |
| 0.098 | 0.111 | 0.101 | Sphingosine 1-phosphate receptor 2 agonist | 0.101 0.099 CID_3565 | CID_3565 | |
| 0.073 | 0.091 | 0.084 | Protein kinase C mu inhibitor | 0.084 0.075 CID_3565 | CID_3565 | |
| 0.064 | 0.083 | 0.122 | Adrenaline agonist | 0.122 0.024 CID_3565 | CID_3565 | |
| 0.031 | 0.052 | 0.122 | NMDA receptor subunit 3B antagonist | 0.122 0.008 CID_3565 | CID_3565 | |
| 0.055 | 0.078 | 0.085 | Protein kinase C beta inhibitor | 0.085 0.024 CID_3565 | CID_3565 | |
| 0.081 | 0.104 | 0.11 | 5 Hydroxytryptamine 3A agonist | 0.11 0.065 CID_3565 | CID_3565 | |
| 0.132 | 0.156 | 0.158 | Catenin beta inhibitor | 0.158 0.087 CID_3565 | CID_3565 | |
| 0.071 | 0.099 | 0.126 | Prolactin inhibitor | 0.126 0.034 CID_3565 | CID_3565 | |
| 0.083 | 0.112 | 0.096 | Cyclin-dependent kinase inhibitor | 0.096 0.094 CID_3565 | CID_3565 | |
| 0.08 | 0.109 | 0.131 | Topoisomerase II inhibitor | 0.131 0.059 CID_3565 | CID_3565 | |
| 0.063 | 0.092 | 0.098 | Estrogen receptor alpha antagonist | 0.098 0.028 CID_3565 | CID_3565 | |
| 0.074 | 0.105 | 0.09 | MAP kinase kinase 1 inhibitor | 0.09 0.07 CID_3565 | CID_3565 | |
| 0.05 | 0.081 | 0.065 | Check point kinase 1 inhibitor | 0.065 0.05 CID_3565 | CID_3565 | |
| 0.013 | 0.046 | 0.025 | Kainate receptor 4 antagonist | 0.025 0.017 CID_3565 | CID_3565 | |
| 0.084 | 0.117 | 0.14 | MAP kinase kinase inhibitor | 0.14 0.057 CID_3565 | CID_3565 | |
| 0.105 | 0.139 | 0.121 | Insulin secretagoues | 0.121 0.11 CID_3565 | CID_3565 | |
| 0.037 | 0.071 | 0.057 | Topoisomerase II beta inhibitor | 0.057 0.024 CID_3565 | CID_3565 | |
| 0.026 | 0.061 | 0.076 | Dopamine D5 agonist | 0.076 0.007 CID_3565 | CID_3565 | |
| 0.123 | 0.161 | 0.134 | ATPase inhibitor | 0.134 0.133 CID_3565 | CID_3565 | |
| 0.026 | 0.067 | 0.033 | Protein kinase C beta I inhibitor | 0.033 0.024 CID_3565 | CID_3565 | |
| 0.058 | 0.1 | 0.089 | Carbonic anhydrase VI inhibitor | 0.089 0.047 CID_3565 | CID_3565 | |
| 0.069 | 0.112 | 0.087 | D-Ala-D-Ala ligase inhibitor | 0.087 0.051 CID_3565 | CID_3565 | |
| 0.104 | 0.147 | 0.118 | Aurora-C kinase inhibitor | 0.118 0.11 CID_3565 | CID_3565 | |
| 0.096 | 0.14 | 0.14 | Thrombolytic | 0.14 0.09 CID_3565 | CID_3565 | |
| 0.067 | 0.112 | 0.083 | Interleukin 5 antagonist | 0.083 0.067 CID_3565 | CID_3565 | |
| 0.136 | 0.183 | 0.237 | Antioxidant | 0.237 0.091 CID_3565 | CID_3565 | |
| 0.114 | 0.161 | 0.134 | Interleukin 6 antagonist | 0.134 0.116 CID_3565 | CID_3565 | |
| 0.061 | 0.108 | 0.074 | GABA B receptor agonist | 0.074 0.057 CID_3565 | CID_3565 | |
| 0.107 | 0.158 | 0.149 | Adenylate cyclase stimulant | 0.149 0.064 CID_3565 | CID_3565 | |
| 0.019 | 0.072 | 0.078 | NMDA receptor subunit 3A antagonist | 0.078 0.012 CID_3565 | CID_3565 | |
| 0.017 | 0.074 | 0.037 | Kinesin antagonist | 0.037 0.025 CID_3565 | CID_3565 | |
| 0.017 | 0.074 | 0.037 | Kinesin-like protein 1 inhibitor | 0.037 0.025 CID_3565 | CID_3565 | |
| 0.05 | 0.109 | 0.066 | Beta 2 adrenoreceptor agonist | 0.066 0.03 CID_3565 | CID_3565 | |
| 0.148 | 0.206 | 0.189 | Lipoxygenase inhibitor | 0.189 0.152 CID_3565 | CID_3565 | |
| 0.105 | 0.166 | 0.129 | Nitric oxide antagonist | 0.129 0.12 CID_3565 | CID_3565 | |
| 0.12 | 0.182 | 0.135 | Ca2+-transporting ATPase inhibitor | 0.135 0.093 CID_3565 | CID_3565 | |
| 0.032 | 0.096 | 0.076 | NMDA 2C receptor antagonist | 0.076 0.028 CID_3565 | CID_3565 | |
| 0.146 | 0.21 | 0.188 | RNA-directed DNA polymerase inhibitor | 0.188 0.118 CID_3565 | CID_3565 | |
| 0.122 | 0.189 | 0.212 | Free radical scavenger | 0.212 0.088 CID_3565 | CID_3565 | |
| 0.096 | 0.166 | 0.132 | Arachidonic acid antagonist | 0.132 0.11 CID_3565 | CID_3565 | |
| 0.121 | 0.192 | 0.145 | Neurotensin receptor agonist | 0.145 0.114 CID_3565 | CID_3565 | |
| 0.051 | 0.123 | 0.085 | Histamine N-methyltransferase inhibitor | 0.085 0.061 CID_3565 | CID_3565 | |
| 0.033 | 0.113 | 0.045 | Beta adrenoreceptor agonist | 0.045 0.032 CID_3565 | CID_3565 | |
| 0.064 | 0.145 | 0.128 | Adenylate cyclase inhibitor | 0.128 0.061 CID_3565 | CID_3565 | |
| 0.102 | 0.184 | 0.174 | Interleukin antagonist | 0.174 0.101 CID_3565 | CID_3565 | |
| 0.152 | 0.234 | 0.176 | Transcription factor STAT inhibitor | 0.176 0.174 CID_3565 | CID_3565 | |
| 0.06 | 0.143 | 0.128 | GABA C receptor agonist | 0.128 0.044 CID_3565 | CID_3565 | |
| 0.077 | 0.161 | 0.146 | Estrogen antagonist | 0.146 0.025 CID_3565 | CID_3565 | |
| 0.068 | 0.152 | 0.132 | Glutamate receptor antagonist | 0.132 0.064 CID_3565 | CID_3565 | |
| 0.127 | 0.221 | 0.161 | Hypoglycemic | 0.161 0.16 CID_3565 | CID_3565 | |
| 0.035 | 0.129 | 0.133 | Porphobilinogen synthase inhibitor | 0.133 0.024 CID_3565 | CID_3565 | |
| 0.057 | 0.154 | 0.104 | Ferrochelatase inhibitor | 0.104 0.067 CID_3565 | CID_3565 | |
| 0.039 | 0.136 | 0.056 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.056 0.052 CID_3565 | CID_3565 | |
| 0.059 | 0.158 | 0.132 | Estrogen receptor beta antagonist | 0.132 0.022 CID_3565 | CID_3565 | |
| 0.029 | 0.129 | 0.055 | Androgen agonist | 0.055 0.048 CID_3565 | CID_3565 | |
| 0.071 | 0.173 | 0.141 | Lipid peroxidase inhibitor | 0.141 0.075 CID_3565 | CID_3565 | |
| 0.128 | 0.23 | 0.185 | MAP-kinase-activated kinase 5 inhibitor | 0.185 0.124 CID_3565 | CID_3565 | |
| 0.077 | 0.18 | 0.239 | Peroxidase inhibitor | 0.239 0.05 CID_3565 | CID_3565 | |
| 0.032 | 0.14 | 0.068 | Histidine decarboxylase inhibitor | 0.068 0.053 CID_3565 | CID_3565 | |
| 0.019 | 0.139 | 0.044 | AMPA 4 receptor antagonist | 0.044 0.02 CID_3565 | CID_3565 | |
| 0.065 | 0.191 | 0.115 | DOPA decarboxylase inhibitor | 0.115 0.051 CID_3565 | CID_3565 | |
| 0.037 | 0.165 | 0.114 | NMDA receptor antagonist | 0.114 0.038 CID_3565 | CID_3565 | |
| 0.005 | 0.138 | 0.035 | Estrogen receptor beta agonist | 0.035 0.022 CID_3565 | CID_3565 | |
| 0.052 | 0.186 | 0.089 | Anabolic | 0.089 0.08 CID_3565 | CID_3565 | |
| 0.016 | 0.155 | 0.033 | Estrogen-related receptor beta antagonist | 0.033 0.02 CID_3565 | CID_3565 | |
| 0.069 | 0.212 | 0.1 | Interleukin 8 antagonist | 0.1 0.096 CID_3565 | CID_3565 | |
| 0.045 | 0.191 | 0.153 | Creatine kinase inhibitor | 0.153 0.023 CID_3565 | CID_3565 | |
| 0.026 | 0.176 | 0.098 | Phenylalanine 4-hydroxylase inhibitor | 0.098 0.026 CID_3565 | CID_3565 | |
| 0.028 | 0.184 | 0.076 | Glutamate decarboxylase inhibitor | 0.076 0.048 CID_3565 | CID_3565 | |
| 0.097 | 0.265 | 0.146 | Phospholipase C inhibitor | 0.146 0.115 CID_3565 | CID_3565 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |